Dexamethasone induce osteoblast apoptosis in a duration- and dose-dependent manner

Area of Science:

• Cell Biology
• Biochemistry
• Pharmacology

Background:

• Osteoblasts are vital for bone formation and preventing osteonecrosis.
• Dexamethasone, a glucocorticoid, can induce osteoblast apoptosis, contributing to non-traumatic osteonecrosis.

Purpose of the Study:

• To investigate the impact of varying dexamethasone doses and treatment durations on rat osteoblast apoptosis in vitro.
• To elucidate the mechanisms underlying dexamethasone-induced osteoblast apoptosis.

Main Methods:

• Osteoblast proliferation was assessed using the cell counting kit-8 (CCK-8) assay.
• Apoptosis was quantified via FITC-Annexin V/PI staining.
• Caspase-3 and -9 expression (mRNA and protein) was analyzed using qRT-PCR and Western blotting.

Main Results:

• Dexamethasone significantly inhibited osteoblast proliferation and induced apoptosis.
• Apoptosis and caspase expression increased in a dose-dependent manner with dexamethasone.
• Apoptosis and caspase expression also increased in a duration-dependent manner with dexamethasone treatment.

Conclusions:

• Dexamethasone induces osteoblast apoptosis.
• The apoptotic effect of dexamethasone on osteoblasts is dependent on both the dose and duration of exposure.
• Findings highlight the risk of dexamethasone in osteonecrosis development.